Page 32 - Ppd Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator Good morning, and welcome to PPD's fourth-quarter and full-year 2020 earnings conference call. Please note, today's call is being recorded. At this time, I'd like to turn the conference over to Tracy Krumme, vice president and head of investor relations for PPD. Ms. Krumme, you may begin. Vice President and Head of Investor Relations Thank you. Good morning, everyone and thank you for joining our fourth-quarter and full-year 2020 earnings call. With me today to discuss our results are David Simmons, PPD's chairman and CEO; Bill Sharbaugh, our COO; and Chris Scully, our CFO. During to...

NEW YORK, NY / ACCESSWIRE / February 24, 2021 / PPD Inc (NASDAQ:PPD) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 24, 2021 at 9:00 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.

Stakeholders in Clinical Trials Market Harness Internet of Medical Things (IoMT) to Explore New Frontiers in Vaccine Development: TMR - Clinical trial management groups harness virtual trial tools to boost recruitment, paving way to innovations ALBANY, N.Y., Feb. 11, 2021 /PRNewswire/ -- Clinical trials community, including industry and the academia, has been relentlessly conducting studies to mitigate and prevent outbreaks of infectious diseases. Ongoing trials around the world underpin hopes of new drugs and therapies. The recent one, COVID-19 pandemic, has brought forth several unique ch...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 ... AzurRx BioPharma, Inc.February 9, 2021 GMT Phase 2 Study of oral niclosamide planned for 1H 2021 DELRAY BEACH, Fla., Feb. 09, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that it has ...

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, will host a conference call on Wednesday, Feb. 24, 2021, at 9 a.m. (U.S. Eastern Time) to discuss its fourth quarter and full-year 2020 financial results. Investors and other interested parties may listen to...